Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Other Working Capital Changes (2019 - 2025)

Historic Other Working Capital Changes for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to -$3.9 million.

  • Outset Medical's Other Working Capital Changes fell 20760.3% to -$3.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.9 million, marking a year-over-year decrease of 20814.02%. This contributed to the annual value of -$1.9 million for FY2025, which is 20814.02% down from last year.
  • According to the latest figures from Q4 2025, Outset Medical's Other Working Capital Changes is -$3.9 million, which was down 20760.3% from $980000.0 recorded in Q3 2025.
  • Outset Medical's 5-year Other Working Capital Changes high stood at $3.6 million for Q4 2024, and its period low was -$3.9 million during Q4 2025.
  • Moreover, its 5-year median value for Other Working Capital Changes was $639500.0 (2021), whereas its average is $395650.0.
  • In the last 5 years, Outset Medical's Other Working Capital Changes soared by 58382.35% in 2022 and then crashed by 2026250.0% in 2024.
  • Over the past 5 years, Outset Medical's Other Working Capital Changes (Quarter) stood at $1.3 million in 2021, then tumbled by 36.44% to $846000.0 in 2022, then grew by 6.5% to $901000.0 in 2023, then soared by 301.44% to $3.6 million in 2024, then plummeted by 207.6% to -$3.9 million in 2025.
  • Its Other Working Capital Changes stands at -$3.9 million for Q4 2025, versus $980000.0 for Q3 2025 and $1.4 million for Q2 2025.